All In MedTech

FDA Clearance Tracker · K240295

InstaStrip Fentanyl Rapid Test (Urine); InstaStrip Fentanyl Dipstick Test (Urine)

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 19, 2026Latest source record: Mar 28, 2024 (this decision)Source: openFDAMethods & limitations

510(k)Breakthrough

Decided

Mar 28, 2024

Substantially Equivalent

Time to decision

56 days

Received Feb 1, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Traditional

Device class

Class II

The decision

FDA number
K240295
Device name
InstaStrip Fentanyl Rapid Test (Urine); InstaStrip Fentanyl Dipstick Test (Urine)
Applicant location
King Of Prussia, PA
Received
Feb 1, 2024
Decided
Mar 28, 2024
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Class II
Regulation
21 CFR 862.3650

Every decision under product code NGL

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code NGL. The earliest in FDA's data is K082898, decided Dec 19, 2008.
  • It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Instanosis, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.